NRSN
NRSN clinical trials: NeuroSense Therapeutics Ltd.
Every trial on ClinicalTrials.gov where NeuroSense Therapeutics Ltd. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 6
- Trials linked
- 6
- As lead sponsor
- 0
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
NRSN on the catalyst calendar · NRSN registry changes
- Primary completion Sep 30, 2025ActualPhase 2NCT06185543A Phase 2, Randomized, Prospective Double-Blind, Single-Center, Placebo-controlled Study to Evaluate Safety, Tolerability, Target...NeuroSense Therapeutics Ltd. · Alzheimer DiseaseTerminatedNRSNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 2, 2023ActualPhase 2NCT05357950A Phase IIb, Multi-Center, Multinational, Double-Blind, Placebo-Controlled Study, With an Open Label Extension, to Evaluate Safety...NeuroSense Therapeutics Ltd. · Amyotrophic Lateral SclerosisCompletedNRSNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 19, 2022ActualPhase 1NCT05436678A Multiple-Dose PK Study to Evaluate the Comparative Bioavailability of PrimeC Tablets to Ciprofloxacin Tablets Co-administered With...NeuroSense Therapeutics Ltd. · PharmacokineticsCompletedNRSNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 21, 2022ActualPhase 1NCT05232461A Pilot Study to Evaluate the PK Profile of PrimeC-ER Tablets in Healthy Adult SubjectsNeuroSense Therapeutics Ltd. · PharmacokineticsCompletedNRSNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 27, 2021ActualPhase 1NCT04090684Ciprofloxacin/Celecoxib Combination in Patients With ALSNeuroSense Therapeutics Ltd. · ALS (Amyotrophic Lateral Sclerosis)CompletedNRSNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 19, 2021ActualPhase 2NCT04165850Open Label Study to Evaluate Ciprofloxacin/Celecoxib Combination in Patients With ALSNeuroSense Therapeutics Ltd. · Amyotrophic Lateral SclerosisCompletedNRSNLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 6 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner